A UC San Diego study suggests that semaglutide, the active ingredient in drugs like Ozempic and Wegovy, may slow biological aging. - The study analyzed data from over 100 adults living with HIV who had excess abdominal fat.
- Participants taking semaglutide showed signs of slower biological aging over 32 weeks. - Researchers found changes in DNA markers linked to inflammation and organ health.
- Lead researcher Michael Corley cautions that larger studies are needed and that diet and exercise remain the benchmark for optimal aging.